Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.

Abstract:

BACKGROUND:Considerable evidence demonstrates the importance of dithiocarbamates especially disulfiram as anticancer drugs. However there are no systematic reviews outlining how their metal-binding ability is related to their anticancer activity. This review aims to summarize chemical features and metal-binding activity of disulfiram and its metabolite DEDTC, and discuss different mechanisms of action of disulfiram and their contributions to the drug's anticancer activity. METHODS:We undertook a disulfiram-related search on bibliographic databases of peerreviewed research literature, including many historic papers and in vitro, in vivo, preclinical and clinical studies. The selected papers were carefully reviewed and summarized. RESULTS:More than five hundreds of papers were obtained in the initial search and one hundred eighteen (118) papers were included in the review, most of which deal with chemical and biological aspects of Disulfiram and the relationship of its chemical and biological properties. Eighty one (81) papers outline biological aspects of dithiocarbamates, and fifty seven (57) papers report biological activity of Disulfiram as an inhibitor of proteasomes or inhibitor of aldehyde dehydrogenase enzymes, interaction with other anticancer drugs, or mechanism of action related to reactive oxygen species. Other papers reviewed focus on chemical aspects of dithiocarbamates. CONCLUSION:This review confirms the importance of chemical features of compounds such as Disulfiram to their biological activities, and supports repurposing DSF as a potential anticancer agent.

journal_name

Curr Med Chem

authors

Viola-Rhenals M,Patel KR,Jaimes-Santamaria L,Wu G,Liu J,Dou QP

doi

10.2174/0929867324666171023161121

subject

Has Abstract

pub_date

2018-02-12 00:00:00

pages

506-524

issue

4

eissn

0929-8673

issn

1875-533X

pii

CMC-EPUB-86483

journal_volume

25

pub_type

杂志文章,评审
  • Pharmacological implications of MMP-9 inhibition by ACE inhibitors.

    abstract::Matrix metalloproteinase-9 (MMP-9) plays an important role in the onset and prognosis of myocardial infarction. Targets of angiotensin converting enzyme (ACE) inhibitors might include not only ACE but also MMP-9, and ACE seems to be closely associated with complications of hypertension such as cardiovascular remodelin...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986709787846514

    authors: Yamamoto D,Takai S

    更新日期:2009-01-01 00:00:00

  • Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins.

    abstract::Stress or heat shock proteins (Hsps) Hsp90, Hsp70 and Hsp27 are chaperones that assist the proteins in their folding, stability, assembly into multi-protein complexes and transport across cellular membranes. The expression of some of them is highly induced in response to a wide variety of physiological and environment...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782360079

    authors: Didelot C,Lanneau D,Brunet M,Joly AL,De Thonel A,Chiosis G,Garrido C

    更新日期:2007-01-01 00:00:00

  • Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management.

    abstract::Antisynthetase syndrome is a group of closely related rare diseases which clinically manifest with inflammatory myopathies, interstitial lung disease, inflammatory arthritis, skin hyperkeratosis (mechanic’s hands) and Raynaud phenomenon. The pathophysiology of antisynthetase syndrome is not entirely understood, but ge...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:

    authors: Mirrakhimov AE

    更新日期:2015-05-13 00:00:00

  • Visible Blue Light Therapy: Molecular Mechanisms and Therapeutic Opportunities.

    abstract:BACKGROUND:Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170727112206

    authors: Garza ZCF,Born M,Hilbers PAJ,van Riel NAW,Liebmann J

    更新日期:2018-01-01 00:00:00

  • Progress towards the discovery of orally active thrombin inhibitors.

    abstract::The serine protease thrombin is a key enzyme in the control of blood coagulation and displays numerous other effects on platelet, endothelial and smooth muscle cell function. The pre-eminence of thrombin in the coagulation cascade has made the enzyme a popular drug target in the search for more clinically acceptable a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: Menear K

    更新日期:1998-12-01 00:00:00

  • Therapeutic constituents and actions of Rubus species.

    abstract::Rubus species (family Rosaceae) have been cultivated for centuries for their fruits. These and other parts of the plants have been used traditionally for therapeutic purposes. This article highlights these and the potential they can offer. The constituents reported in the various species and those demonstrated to exhi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867043365143

    authors: Patel AV,Rojas-Vera J,Dacke CG

    更新日期:2004-06-01 00:00:00

  • Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives.

    abstract::TB drug development pipeline represents varied structural classes of molecules. Oxazolidinones represent synthetic anti-bacterial agents with unique mechanism of action having wide spectrum of activity, oral bioavailability and well established SAR. They act by inhibiting translation at the initiation phase of protein...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666151106125759

    authors: Jadhavar PS,Vaja MD,Dhameliya TM,Chakraborti AK

    更新日期:2015-01-01 00:00:00

  • Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.

    abstract::The discovery of the high-affinity, high-specificity folate receptor in mamalian kidney cells, coupled with the ability of folate to enter cells by folate receptor-mediated endocytosis and the subsequent elucidation of the folate receptor's overexpression in specific cancer cell types; heralded the arrival of the area...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180209143715

    authors: Carron PM,Crowley A,O'Shea D,McCann M,Howe O,Hunt M,Devereux M

    更新日期:2018-01-01 00:00:00

  • Peptide immunotherapies in Type 1 diabetes: lessons from animal models.

    abstract::Insulin dependent diabetes mellitus (Type 1 diabetes, T1D) is a chronic autoimmune disorder characterized by the destruction of insulin-producing pancreatic beta cells by proinflammatory autoreactive T cells. In the past, several therapeutic approaches have been exploited by immunologists aiming to regulate the autoim...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711794480230

    authors: Fierabracci A

    更新日期:2011-01-01 00:00:00

  • Lipoxygenase inhibitors as cancer chemopreventives: discovery, recent developments, and future perspectives.

    abstract:BACKGROUND:Leukotrienes (LTs) constitute a bioactive group of polyunsaturated fatty acid (PUFA) metabolites molded by the enzymatic activity of lipoxygenase (LO) and have a pivotal role in inflammation and allergy. Evidence is accumulating both by in vitro cell culture experiments and animal tumor model studies in supp...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867326666191210104820

    authors: Mahboubi-Rabbani M,Zarghi A

    更新日期:2019-12-09 00:00:00

  • Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes.

    abstract::Existence of residual cancers and recurrence of cancers are two major limitations of conventional therapies against cancers. A naturally-occurring defense system against tumor may be established in cancer patients by induction of antitumor immunity. Both polyvalent and tumor antigen-defined vaccines have been administ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706778742882

    authors: Fazle Akbar SM,Abe M,Yoshida O,Murakami H,Onji M

    更新日期:2006-01-01 00:00:00

  • Impact of Natural Dietary Agents on Multiple Myeloma Prevention and Treatment: Molecular Insights and Potential for Clinical Translation.

    abstract::Chemoprevention is based on the use of non-toxic, pharmacologically active agents to prevent tumor progression. In this regard, natural dietary agents have been described by the most recent literature as promising tools for controlling onset and progression of malignancies. Extensive research has been so far performed...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867325666180629153141

    authors: Raimondi L,De Luca A,Giavaresi G,Barone A,Tagliaferri P,Tassone P,Amodio N

    更新日期:2020-01-01 00:00:00

  • Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.

    abstract::A BRAF somatic mutation at residue 600 of the BRAF protein (BRAFV600E) is highly prevalent in papillary thyroid carcinomas (PTC). This mutation occurs in approximately 44% (from 29% to 83%) of PTC depending on the different studies. BRAFV600E is almost always found in PTC with a papillary or a mixed follicular/papilla...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710791111189

    authors: Lassalle S,Hofman V,Ilie M,Butori C,Bozec A,Santini J,Vielh P,Hofman P

    更新日期:2010-01-01 00:00:00

  • Diseases originating from altered protein quality control in the endoplasmic reticulum.

    abstract::A challenging question in biology is how cells control their shape and volume. The relative abundance of organelles can be radically modified to comply with a new task, an example being the massive development of the endoplasmic reticulum (ER) in Ig-secreting plasma cells. The ER is the site where secretory proteins a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707780830952

    authors: Otsu M,Sitia R

    更新日期:2007-01-01 00:00:00

  • The glutamate hypothesis in ALS: pathophysiology and drug development.

    abstract::Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is believed to have complex genetic and environmental influences in the pathogenesis, but etiologies are unidentified for most patients. Until the major causes are better defined, drug development is directed at downstream pathophysi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666140916120118

    authors: Blasco H,Mavel S,Corcia P,Gordon PH

    更新日期:2014-01-01 00:00:00

  • Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.

    abstract::Cellular interactions among platelets, leukocytes and endothelial cells are considered as a major cause of inflammation and atherosclerosis in many diseases. Via exposed surface receptors and released soluble substances, activated platelets play a crucial role in the initiation of inflammatory processes, resulting in ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712798918770

    authors: Nagy B Jr,Miszti-Blasius K,Kerenyi A,Clemetson KJ,Kappelmayer J

    更新日期:2012-01-01 00:00:00

  • The glioblastoma problem: targeting by combined medicinal chemistry approaches.

    abstract::Whilst knowledge of basic biology, diagnosis and prognosis of glioblastoma (GB - WHO grade IV) are steadily improving, advancements of therapy are discouragingly slow, with the only significant novelty during last ten years represented by introduction of temozolomide in chemotherapy. In order to analyze the current st...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150530210700

    authors: Frosina G

    更新日期:2015-01-01 00:00:00

  • Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation.

    abstract::Osteoporosis is characterized by reduced bone mass and structural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. Bone loss further increases in postmenopausal women when the ovaries stop making estrogens. Women undergoing treatment for osteoporosis require l...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710791959738

    authors: Bitto A,Polito F,Squadrito F,Marini H,D'Anna R,Irrera N,Minutoli L,Granese R,Altavilla D

    更新日期:2010-01-01 00:00:00

  • Intravenous and regional paclitaxel formulations.

    abstract::Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for sy...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867043455981

    authors: Pawar R,Shikanov A,Vaisman B,Domb AJ

    更新日期:2004-02-01 00:00:00

  • The Role of (Modified) Lipoproteins in Vascular Function: A Duet Between Monocytes and the Endothelium.

    abstract::Over the last century, many studies have demonstrated that low-density lipoprotein (LDL) is a key risk factor of cardiovascular diseases (CVD) related to atherosclerosis. Thus, for these CVD patients, LDL lowering agents are commonly used in the clinic to reduce the risk for CVD. LDL, upon modification, will develop d...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180316121015

    authors: Schnitzler JG,Dallinga-Thie GM,Kroon J

    更新日期:2019-01-01 00:00:00

  • Progress in COX-2 inhibitors: a journey so far.

    abstract::The non-steroidal anti-inflammatory drugs (NSAIDs) are diverse group of compounds used for the treatment of inflammation, since the introduction of acetylsalicylic acid in 1899. Traditional (first generation) NSAIDs exert antiinflammatory, analgesic, and antipyretic effects through the blockade of prostaglandin synthe...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710790979980

    authors: Chakraborti AK,Garg SK,Kumar R,Motiwala HF,Jadhavar PS

    更新日期:2010-01-01 00:00:00

  • Current knowledge on the antagonists and inverse agonists of cannabinoid receptors.

    abstract::Ten years elapsed since the discovery by Sanofi of SR141716A the first selective CB(1) cannabinoid receptor antagonist. Shortly after, Sanofi also reported the synthesis of the first selective CB(2) cannabinoid receptor antagonist, SR144528. Since these two milestones in the cannabinoid field, many other compounds, mo...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867054020891

    authors: Muccioli GG,Lambert DM

    更新日期:2005-01-01 00:00:00

  • Phenylpropanoid sucrose esters: plant-derived natural products as potential leads for new therapeutics.

    abstract::Natural products are regarded as vital key source of lead compounds for drug discovery due to their structural diversity and broad array of biological activities. Phenylpropanoid sucrose esters are naturally occurring compounds isolated from various plants and are structurally characterized by a sucrose core connected...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796391589

    authors: Panda P,Appalashetti M,Judeh ZM

    更新日期:2011-01-01 00:00:00

  • Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

    abstract::Human immunodeficiency virus (HIV) infection commonly results in a myriad of comorbid conditions secondary to immune deficiency. Infection also affects broad organ system function. Although current antiretroviral therapy (ART) reduces disease morbidity and mortality through effective control of peripheral viral load, ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666140826114135

    authors: Edagwa BJ,Zhou T,McMillan JM,Liu XM,Gendelman HE

    更新日期:2014-01-01 00:00:00

  • Chemical and pharmacological aspects of heteroaryl-nitrones.

    abstract::Radical induced oxidative damage is extremely harmful to tissues and organs due to molecular modifications brought to polyunsaturated membrane lipids, proteins and nucleic acids. Oxidative stress is believed to be one of the pathophysiological mechanisms that operate in neurodegenerative disorders such as cerebral isc...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867003374183

    authors: Goldstein S,Lestage P

    更新日期:2000-12-01 00:00:00

  • Updates on Managing Type 2 Diabetes Mellitus with Natural Products: Towards Antidiabetic Drug Development.

    abstract::Over the years, natural products have shown success as antidiabetics in in vitro, in vivo studies and clinical trials. Because natural product-derived drugs are more affordable and effective with fewer side-effects compared to conventional therapies, pharmaceutical research is increasingly leaning towards the discover...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160813222436

    authors: Alam F,Islam MA,Kamal MA,Gan SH

    更新日期:2018-01-01 00:00:00

  • Discovery of Hedgehog Antagonists for Cancer Therapy.

    abstract:BACKGROUND:The evolutionarily conserved Hedgehog (Hh) signaling cascade is one of the key mediators of embryonic development of many metazoans. This pathway has been extensively targeted by small molecule inhibitors as its misregulation leads to various malignancies and developmental disorders. Thus, blocking this path...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170316115500

    authors: Khatra H,Bose C,Sinha S

    更新日期:2017-01-01 00:00:00

  • Regulation of mast cell development by inflammatory factors.

    abstract::Mast cells are potent effectors playing a key role in IgE-associated hypersensitivity reactions, allergic disorders, inflammation and protective immune responses. Mast cell development in vivo occurs mainly in non-hematopoietic microenvironments and increased mast cell numbers can be seen in various inflammatory disea...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782793998

    authors: Hu ZQ,Zhao WH,Shimamura T

    更新日期:2007-01-01 00:00:00

  • Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development.

    abstract::Adenosine is an important autocoid, exerting its physiological effects on the human body by activation of four different G-protein-coupled-receptors (GPCRs) classified as A(1), A(2A), A(2B), and A(3). These receptors are coupled to secondary messenger systems including adenylate cyclase, inositol phosphate metabolism,...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710792927831

    authors: Romagnoli R,Baraldi PG,Tabrizi MA,Gessi S,Borea PA,Merighi S

    更新日期:2010-01-01 00:00:00

  • Preterm labour: an overview of current and emerging therapeutics.

    abstract::Preterm labour is a major cause of perinatal mortality and morbidity. However, during the past 40 years of clinical studies and despite the use of multiple therapeutic agents, the rate of preterm birth has not drastically declined. In 1991, it was estimated that in the US approximately 116,000 women admitted with acut...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457331

    authors: Schwarz MK,Page P

    更新日期:2003-08-01 00:00:00